Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Vasodilator agents" patented technology

Vasodilator (vā´zōdī´lātur), n 1. an agent that causes dilation of the blood vessels. n 2. a drug that relaxes the smooth muscle walls of the blood vessels and increases their diameter.

Application of high temperature-resistant alpha-rhamnosidase gene and its transformation of rutin to isoquercetin

The invention relates to heat-resistant alpha-rhamnosidase, which can efficiently transform rutin to isoquercetin, and the heat-resistant alpha-rhamnosidase of the invention has excellent thermal stability; the alpha-rhamnosidase of the present invention can be almost completely transformed after being incubated with rutin under suitable conditions, and more active isoquercetin can be obtained.
Owner:INST OF CHEM IND OF FOREST PROD CHINESE ACAD OF FORESTRY

Human immunity enhancer for cancer prevention and treatment as well as preparation method of human immunity enhancer

The invention discloses a human immunity enhancer for cancer prevention and treatment. The human immunity enhancer comprises components in parts by weight as follows: 111-222 parts of Echinacea phenol, 144-288 parts of astragaloside, 111-177 parts of chrysin, 333-666 parts of coriolus versicolor polysaccharide, 22-33 parts of diindolymethane, 60-111 parts of resveratrol, 80-111 parts of curcumin,111-222 parts of dihydroquercetin, 111-222 parts of tea polyphenols, 2.22-11.1 parts of L-selenomethionine, 80-130 parts of phosphatidylcholine, 90-140 parts of phosphatidylserine, 444-888 parts of methionine and 3000-4000 parts of a lipidosome matrix emulsion. The natural traditional Chinese medicine extracts and multiple active compounds are matched in proportion, a lipidosome matrix convenientto absorb is adopted, the immunity of the human body can be improved, and cancer, AIDS and other immunodeficiency diseases can be resisted effectively.
Owner:李胜

Detection method of pharmaceutical composition mammary lump relieving capsule for treating hyperplasia of mammary glands and mastitis

ActiveCN110927281ASensitive quality control standardsStrong specificityComponent separationMastitisBULK ACTIVE INGREDIENT
The invention relates to a detection method of a pharmaceutical composition for treating hyperplasia of mammary glands and mastitis, in particular to a detection method of a mammary lump relieving capsule for treating hyperplasia of mammary glands and mastitis, which adds high performance liquid chromatography content determination of active ingredient quercetin in monarch drug trichosanthes peeland minister drug dandelion on the basis of the original quality standard. The detection method is sensitive, strong in specificity, accurate and good in reproducibility, and can make up for the defects of the existing method, effectively control the quality of the medicine and enable the quality of the medicine to be associated with effective components of clinical treatment, so that the stable,controllable, efficient and safe standard is achieved, and the medical requirements are further better met.
Owner:XIAN CHIHO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products